7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Published data on the safety of tetanus-diphtheria-acellular pertussis vaccine (Tdap) in persons aged ≥65 years are limited. This study aims to examine a large cohort of Tdap users ≥65 years for evidence of increased risk of adverse events following vaccination.

          Related collections

          Author and article information

          Journal
          Clin. Infect. Dis.
          Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
          Oxford University Press (OUP)
          1537-6591
          1058-4838
          Feb 2013
          : 56
          : 3
          Affiliations
          [1 ] Kaiser Permanente Southern California, Pasadena, CA 91101, USA. hung-fu.x.tseng@kp.org
          Article
          cis871
          10.1093/cid/cis871
          23196953
          b4cb8d58-8105-4084-9970-38a2b60cdfd1
          History

          Comments

          Comment on this article